HomeOpen Access NewsDiseases & Conditions

Diseases & Conditions

New study reveals over 400,000 people are affected by ME/CFS in the UK

Research from The University of Edinburgh has found that almost two-thirds more people are living with ME/CFS in England than previously recorded.

The importance of the gut microbiome in chronic digestive diseases

Leading digestive health experts and MEP Sarah Wiener address how healthy nutrition, starting from a young age, can help to reduce the risk of chronic digestive diseases and improve the health of our gut microbiome.

Health research in Africa: Infectious diseases of humans and animals

Gerald Misinzo and Mark Rweyemamu from SACIDS Foundation for One Health provide a detailed look at one health research by the Africa centres of excellence for infectious diseases of humans and animals.

Dementia in the digital era: A Hong Kong perspective

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group shines the spotlight on dementia in the digital era, from a Hong Kong perspective.

Obesity in Europe: An urgent and relevant health priority for policymakers

Jacqueline Bowman-Busato, EU Policy Lead at the European Association for the Study of Obesity, explains why obesity in Europe is an urgent and relevant health priority for policymakers, NGOs, research funders, health professionals and the public.

Heart and vascular health research: A focus on cardiovascular sciences

David Goff, MD, PhD, Director, Division of Cardiovascular Sciences at the National Heart, Lung, and Blood Institute at the National Institutes of Health in the U.S., introduces the work of the organisation and his thoughts on supporting heart and vascular health research.

Learning from COVID-19: Can we prepare for future epidemics?

Margaret Heffernan, Author of Uncharted, shares her thoughts about how AI, big data and forecasting might not be the solution to the coronavirus, and how society should really be preparing itself for more inevitable epidemics.

Graph theory in the study of Alzheimer’s disease progression

María J. Peláez1, Prashant Dogra1, Zhihui Wang1, Vittorio Cristini1 1Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX 77030, USA.

Soluble circulating cytokine receptors in chronic inflammatory lung diseases

Michael Roth discusses soluble circulating cytokine receptors in chronic inflammatory lung diseases, which he describes as the under-estimated regulators of inflammation and remodelling.

Europe deserves more and better research & innovation in cardiovascular disease

Prof Lina Badimon, Chair, ESC Advocacy Committee 2018-2020 Director, Cardiovascular Program (ICCC) – IR, Hospital de la Santa Crue I Sant Pau, argues that Europe deserves more and better research & innovation in cardiovascular disease.

A focus on rare disease: Paroxysmal nocturnal haemoglobinuria (PNH)

Maria Piggin, Chair of PNH Support tells us about the rare disease, paroxysmal nocturnal haemoglobinuria (PNH) and in this area, collaborations for change.

Leading a normal life with a Noonan Syndrome child: Benji Ballard’s story

Katie Ballard, a trustee of the Noonan Syndrome Association, shares her story of son Benjamin after receiving a life-changing diagnosis of Noonan Syndrome and cardiomyopathy.

Pulmonary rehabilitation: Changing the lives of patients with lung disease

Jessica Eagelton, co-chair of the Taskforce for lung Health Pulmonary Rehabilitation working group, discusses Pulmonary rehabilitation: a drug-free treatment that is changing the lives of people with lung disease.

European Commission announces €232 million aid package to tackle COVID-19

In a bid to tackle the recent outbreak of COVID-19 the European Commission has announced a new aid package worth €232 million.

Global Food Research: Will front-of-the-package warning labels change our eating habits?

The Global Food Research Program shares their perspective on targeting ultra-processed foods with front-of-the-package warning labels, which is the only impactful approach.

The 2010s: Advances witnessed in muscle-wasting conditions research

Kate Adcock, Director of Research and Innovation, Muscular Dystrophy UK, charts the advances over the past decade in muscle-wasting conditions research.

Assessment and surveillance to mitigate infectious diseases in Africa

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, gives a call to action when it comes to assessment and surveillance to mitigate the impact of infectious diseases in Africa.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders